CEACAM5 and neoplasm: For this exercise, we considered the tumor cytotoxicity of two drugs with low (cibisatamab, KD = 48.6 nM) and high (CEACAM5-TCB, KD = 13.1 nM) binding affinities for the same tumor target (CEA).